Tango Therapeutics, Inc. (TNGX) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $1.05M | +39.0% |
| 2024 | $754.0K | -50.6% |
| 2023 | $1.53M | -80.2% |
| 2022 | $7.69M | +318.7% |
| 2021 | $1.84M | +66.1% |
| 2020 | $1.11M | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $1.05M | +39.0% |
| 2024 | $754.0K | -50.6% |
| 2023 | $1.53M | -80.2% |
| 2022 | $7.69M | +318.7% |
| 2021 | $1.84M | +66.1% |
| 2020 | $1.11M | — |